 | Up a level |
Vakhshiteh, F. and Rahmani, S. and Ostad, S.N. and Madjd, Z. and Dinarvand, R. and Atyabi, F. (2021) Exosomes derived from miR-34a-overexpressing mesenchymal stem cells inhibit in vitro tumor growth: A new approach for drug delivery. Life Sciences, 266.
Gheytanchi, E. and Naseri, M. and Karimi-Busheri, F. and Atyabi, F. and Mirsharif, E.S. and Bozorgmehr, M. and Ghods, R. and Madjd, Z. (2021) Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines. Cancer Cell International, 21 (1).
Vakhshiteh, F. and Khabazian, E. and Atyabi, F. and Ostad, S.N. and Madjd, Z. and Dinarvand, R. (2020) Peptide-conjugated liposomes for targeted miR-34a delivery to suppress breast cancer and cancer stem-like population. Journal of Drug Delivery Science and Technology, 57.
Bahrami, Z. and Badiei, A. and Atyabi, F. and Darabi, H.R. and Mehravi, B. (2015) Piperazine and its carboxylic acid derivatives-functionalized mesoporous silica as nanocarriers for gemcitabine: Adsorption and release study. Materials Science and Engineering C, 49. pp. 66-74.
